"Ribonucleosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
| Descriptor ID |
D012263
|
| MeSH Number(s) |
D13.570.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ribonucleosides".
Below are MeSH descriptors whose meaning is more specific than "Ribonucleosides".
This graph shows the total number of publications written about "Ribonucleosides" by people in this website by year, and whether "Ribonucleosides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ribonucleosides" by people in Profiles.
-
The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGF?-induced pulmonary fibrosis. Br J Pharmacol. 2015 Aug; 172(16):4173-88.
-
Predictors of contemporary coronary artery bypass grafting outcomes. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2720-6.e1-2.
-
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. JAMA. 2012 Jul 11; 308(2):157-64.
-
GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis. Mol Pharmacol. 1995 May; 47(5):948-55.
-
Mizoribine pharmacokinetics and pharmacodynamics in a canine renal allograft model of local immunosuppression. Transplantation. 1992 Jan; 53(1):12-9.